Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 0.62 |
| ▸ | CNR1 | P21554 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29413745 | 1.00 | CNR2 (0.62) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL29415349 | 1.00 | CNR2 (0.62) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL476866 | 1.00 | CNR2 (0.62) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL29391189 | 0.95 | CNR2 (0.59) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL262367 | 0.95 | CNR2 (0.59) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL15387690 | 0.91 | CNR2 (0.58) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL9266413 | 0.91 | CNR2 (0.54) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL9762472 | 0.90 | CNR2 (0.68) | CNR2CNR1ALDH1A1NPC1 | |
| SCHEMBL13318972 | 0.87 | CNR2 (0.51) | CNR2CNR1ALDH1A1TSHRMAPK1 | |
| SCHEMBL23533403 | 0.86 | CNR2 (0.48) | CNR2ALDH1A1TSHRMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2820073-B1 | GLOSS-CONTROLLABLE, RADIATION-CURABLE INKJET INK | ELECTRONICS FOR IMAGING INC (US) | 2018-09-05 | — | — | EP | claimed |
| US-9260616-B2 | Gloss-controllable, radiation-curable inkjet ink | ELECTRONICS FOR IMAGING, INC. (US) | 2016-02-16 | — | — | US | claimed |
| CN-104508025-A | Gloss-controllable, radiation-curable inkjet inks | ELECTRONICS FOR IMAGING INC | 2015-04-08 | — | — | CN | claimed |
| US-20130222499-A1 | GLOSS-CONTROLLABLE, RADIATION-CURABLE INKJET INK | GLAS USA LLC [SUCCESSOR COLLATERAL AGENT] | 2013-08-29 | — | — | US | claimed |
| US-7670749-B2 | Resist material and method for forming a patterned resist layer on a substrate | THE UNIVERSITY OF BIRMINGHAM (GB) | 2010-03-02 | — | — | US | claimed |
| EP-1789850-B1 | NOVEL RESIST MATERIAL AND METHOD FOR FORMING A PATTERNED RESIST LAYER ON A SUBSTRATE | UNIV BIRMINGHAM (GB) | 2008-10-01 | — | — | EP | claimed |
| US-20070298328-A1 | Novel Resist Material and Method for Forming a Patterned Resist Layer on a Substrate | UNIVERSITY OF BIRMINGHAM, THE (GB) | 2007-12-27 | — | — | US | claimed |
| EP-1789850-A2 | NOVEL RESIST MATERIAL AND METHOD FOR FORMING A PATTERNED RESIST LAYER ON A SUBSTRATE | The University of Birmingham (GB) | 2007-05-30 | — | — | EP | claimed |
| WO-2006030239-A2 | NOVEL RESIST MATERIAL AND METHOD FOR FORMING A PATTERNED RESIST LAYER ON A SUBSTRATE | THE UNIVERSITY OF BIRMINGHAM (GB) | 2006-03-23 | — | — | WO | claimed |
| US-20020042022-A1 | Alkylphenylbisacylphosphine oxides and photoinitiator mixtures | LEPPARD DAVID GEORGE (CH) | 2002-04-11 | — | — | US | claimed |
| US-6361925-B1 | WHICH ARE CAPABLE OF CURING PHOTOPOLYMERIZABLE COMPOSITIONS EFFICIENTLY AND WITHOUT EXTREME YELLOWING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-26 | — | — | US | claimed |
| US-12548830-B2 | All-solid-state battery and photocurable composition used in all-solid-state battery | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2026-02-10 | — | — | US | disclosed |
| EP-3765060-B1 | EMBEDDING MEDIUM OF BIOLOGICAL SAMPLE FOR ITS IMAGING BY LIGHT AND/OR ELECTRON MICROSCOPY | CRYOCAPCELL (FR) | 2025-09-03 | — | — | EP | disclosed |
| US-20250199401-A1 | RESIN COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND DISPLAY DEVICE | TORAY INDUSTRIES, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| US-20250172873-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED ARTICLE, METHOD FOR MANUFACTURING CURED ARTICLE, ORGANIC EL DISPLAY DEVICE, AND DISPLAY DEVICE | TORAY INDUSTRIES, INC. (JP) | 2025-05-29 | — | — | US | disclosed |
| US-20020137816-A1 | Phase change inks | XEROX CORPORATION | 2002-09-26 | — | — | US | disclosed |
| US-20020042022-A1 | Alkylphenylbisacylphosphine oxides and photoinitiator mixtures | LEPPARD DAVID GEORGE (CH) | 2002-04-11 | — | — | US | disclosed |
| US-6361925-B1 | WHICH ARE CAPABLE OF CURING PHOTOPOLYMERIZABLE COMPOSITIONS EFFICIENTLY AND WITHOUT EXTREME YELLOWING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-26 | — | — | US | disclosed |
| US-6336963-B1 | INK COMPOSITION COMPRISING INK VEHICLE COMPRISING FIRST NITRILE COMPOUND HAVING FIRST VISCOSITY AT MELT TEMPERATURE, VISCOSITY MODIFIER COMPRISING SECOND NITRILE COMPOUND HAVING LOWER VISCOSITY AT MELT TEMPERATURE, COLORANT | XEROX CORPORATION | 2002-01-08 | — | — | US | disclosed |
| US-6020528-A | Alkylphenylbisacylphosphine oxides and photoinitiator mixtures | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12548830-B2 | All-solid-state battery and photocurable composition used in all-solid-state battery | SETDB1, SEM1, EIF2B1 | CNR2 4695/4885CNR1 4773/4885ALDH1A1 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.